Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nevus, Sebaceous of Jadassohn × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 29 Fatigue 23 Depression 22 Prostatic Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 14 Multiple Myeloma 13 Colorectal Neoplasms 13 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Lung Neoplasms 11 Leukemia, Myeloid, Acute 11 Hodgkin Disease 11 Leukemia, Myeloid, Chronic-Phase 10 Blast Crisis 10 Pain 9 Lymphoma, T-Cell, Cutaneous 9 Leukemia, Myeloid, Accelerated Phase 9 Leukemia, Hairy Cell 9 Anxiety Disorders 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8 Carcinoma, Ovarian Epithelial 8 Vomiting 7 Sezary Syndrome 7

Interventions

burosumab 2 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04320316 2022-10-07

ENS

University of Alabama at Birmingham

Phase 4 Completed

1 enrolled 10 charts

Nevus, Sebaceous of Jadassohn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡